Neurosurgical Issues in Brain Tumor Management


Robert R. Goodman, MD, PhD Chairman of the Department of Neurosurgery   at St. Luke’s and Roosevelt Hospitals and Beth Israel Medical Center, discusses the epidemiology and diagnosis of brain tumors, optimal care strategies, stereotactic radiosurgery, and evidence-based treatments, with illustrative case examples.

Target Audience

Primary care physicians and internists who wish to learn more about surgical treatment of brain tumors. 

Objectives

• Summarize the Class I evidence available regarding the treatment of brain tumors
• Discuss the major factors determining outcomes for brain tumor patients
• Discuss how stereotactic radiosurgery has transformed the treatment of brain tumor patients

Accreditation Statement

Beth Israel Medical Center and St. Luke’s and Roosevelt Hospitals are accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

St. Luke’s and Roosevelt Hospitals designate this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure

It is the policy of Beth Israel Medical Center and St. Luke's and Roosevelt Hospitals that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. Beth Israel Medical Center and St. Luke's and Roosevelt Hospitals have established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following have reported that they do not have any financial relationships to disclose:

Presenter

Robert R. Goodman, MD, PhD

Robert R. Goodman, MD, PhD Robert R. Goodman, MD, PhD, became Chairman of the Department of Neurosurgery at St. Luke’s and Roosevelt Hospitals and Beth Israel Medical Center in 2011, after 19 years at Columbia-Presbyterian Medical Center.
View Full Profile